International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13960255
Original Research Article
Accuracy of Mammography and Ultrasound in Detecting Breast Cancer A Prospective Comparative Study
Published
Oct. 21, 2024
Abstract

Background: Breast cancer remains a significant public health concern, and the early detection of the disease is crucial for improving patient outcomes. This prospective, comparative study aimed to meticulously evaluate and compare the accuracy of mammography and ultrasound in detecting breast cancer, focusing on their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).Methods: A total of 250 women aged 40 to 75 years, presenting for routine screening or with symptomatic breast complaints, were included in the study. Participants underwent digital mammography and high-resolution ultrasound examinations, with the findings classified according to the Breast Imaging Reporting and Data System (BI-RADS). Biopsy-confirmed results served as the reference standard.Results: Of the 250 participants, 36 (14.4%) were found to have biopsyconfirmed breast cancer. Ultrasound demonstrated a higher sensitivity of 94.4% (95% CI: 80.8%-99.3%) compared to mammography at 83.3% (95% CI: 67.2%-93.6%), with a statistically significant difference in detection rates (p = 0.031). The combined use of both modalities achieved the highest sensitivity of 97.2% (95% CI: 85.5%-99.9%). The specificity was 89.4% for mammography and 87.0% for ultrasound, with a modest decrease to 86.4% for the combined approach. The PPV ranged from 57.4% to 60.0%, while the NPV was exceptionally high, reaching 99.5% for the combined modalities.Conclusion: Ultrasound demonstrated superior sensitivity compared to mammography in detecting breast cancer, particularly in women with dense breasts. The combined use of both modalities resulted in the highest sensitivity, suggesting that a multimodal approach may be the most effective strategy for comprehensive breast cancer screening and diagnosis.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
718 Views
377 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved